In order to further promote the continuous development of tumor diagnosis and treatment, improve the quality of clinical treatment, and strengthen academic exchanges in the region, Chengdu High-tech Medical Association held a training course on new progress in tumor diagnosis and treatment on June 19, 2021.

The meeting invited Professor Xie Ke from Sichuan Provincial People's Hospital to give an opening speech and summary; Professor Zhou Lin from West China Hospital of Sichuan University focused on sharing "SPD-L1 Inhibitor Re-challenge and Driver Gene Positive NSCLC Back-line Immunotherapy"; Sichuan Province Professor Rui Ao of the People's Hospital focused on "From Guidelines to Practice: Discussion on Hot Issues in the Management of Immune-related Adverse Reactions." The participating experts and professors conducted topical questions, opinions sharing and discussions based on the reports of experts and scholars.

This conference provides a platform for clinical medical practitioners and scientific researchers to exchange diagnosis and treatment technology and academic research results, which is conducive to promoting the academic development of clinical scientific research and medical oncology, and is useful for promoting high-quality clinical research in the field of medical oncology. It is of great significance to promote the level of clinical scientific research.